Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Cardiff Oncology, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 116 | 1 | 115 | 0 |
| Shares | 32.3M | 101.6K | 28.7M | −3.58M (−11.1%) |
| Value | $101.6M | $318.9K | $90.3M | −$11.0M (−10.8%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Cardiff Oncology, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 130,352 | $410.6K | 0.02% |
| Renaissance Technologies LLC | 129,690 | $408.5K | 0.00% |
| AlphaCore Capital LLC | 101,575 | $320.0K | 0.01% |
| Atom Investors LP | 71,051 | $223.8K | 0.02% |
| Flputnam Investment Management Co | 53,863 | $169.7K | 0.00% |
| Los Angeles Capital Management LLC | 24,655 | $77.7K | 0.00% |
| Quadrature Capital Ltd | 23,117 | $72.9K | 0.00% |
| Graham Capital Management, L.P. | 18,718 | $59.0K | 0.00% |
| Lido Advisors, LLC | 15,000 | $47.3K | 0.00% |
| Wolverine Trading, LLC | 14,573 | $45.9K | 0.00% |
| Engineers Gate Manager LP | 13,585 | $42.8K | 0.00% |
| Integrity Alliance, LLC. | 12,860 | $40.5K | 0.00% |
| Scarborough Advisors, LLC | 7,502 | $23.6K | 0.00% |
| Baader Bank INC | 10,022 | $19.5K | 0.00% |
| Larson Financial Group LLC | 328 | $1.03K | 0.00% |
| SRS Capital Advisors, Inc. | 304 | $958 | 0.00% |
| Jones Financial Companies LLLP | 50 | $158 | 0.00% |
| IFP Advisors, Inc | 0 | $103 | 0.00% |
| National Bank of Canada | 32 | $101 | 0.00% |
Sold out (19)
Institutions that held Cardiff Oncology, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Commodore Capital LP | 5,384,616 | $16.9M |
| Citadel Advisors LLC | 757,840 | $2.38M |
| OrbiMed Advisors LLC | 573,884 | $1.80M |
| DAFNA Capital Management LLC | 150,000 | $471.0K |
| Squarepoint Ops LLC | 127,965 | $401.8K |
| Yarbrough Capital, LLC | 88,163 | $276.8K |
| Corebridge Financial, Inc. | 28,555 | $89.7K |
| HB Wealth Management, LLC | 26,701 | $83.8K |
| SG Americas Securities, LLC | 23,029 | $72.0K |
| Thoroughbred Financial Services, LLC | 19,614 | $61.0K |
| Virtu Financial LLC | 19,212 | $60.0K |
| Caxton Corp | 13,287 | $41.7K |
| CIBC World Markets Corp | 12,934 | $40.6K |
| Tortoise Investment Management, LLC | 10,000 | $31.4K |
| CoreCap Advisors, LLC | 8,000 | $25.1K |
| Signaturefd, LLC | 3,607 | $11.3K |
| Caitong International Asset Management Co., Ltd | 2,282 | $7.17K |
| True Wealth Design, LLC | 14 | $44 |
| EverSource Wealth Advisors, LLC | 2 | $6 |
Not filed for Q2 2025 yet (1)
Institutions that held Cardiff Oncology, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Callan Capital, LLC | 101,575 | $318.9K |